These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30389133)

  • 1. LncRNA cancer susceptibility candidate 15 accelerates the breast cancer cells progression via miR-153-3p/KLF5 positive feedback loop.
    Yu L; Xu Q; Yu W; Duan J; Dai G
    Biochem Biophys Res Commun; 2018 Dec; 506(4):819-825. PubMed ID: 30389133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CASC15, MiR-23b Cluster and SMAD3 form a Novel Positive Feedback Loop to promote Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.
    Lin H; Xu X; Chen K; Fu Z; Wang S; Chen Y; Zhang H; Niu Y; Chen H; Yu H; Shao JZ; Lu W; Wu Y; Xia D
    Int J Biol Sci; 2022; 18(5):1989-2002. PubMed ID: 35342355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p.
    Yu DJ; Zhong M; Wang WL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7943-7949. PubMed ID: 31599419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krüppel-like factor 5-induced overexpression of long non-coding RNA DANCR promotes the progression of cervical cancer via repressing microRNA-145-3p to target ZEB1.
    Hu C; Han Y; Zhu G; Li G; Wu X
    Cell Cycle; 2021 Jul; 20(14):1441-1454. PubMed ID: 34233586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA ENST00000422059 promotes cell proliferation and inhibits cell apoptosis in breast cancer by regulating the miR-145-5p/KLF5 axis.
    Zhu Y; Ren J; Wu X; Zhang Y; Wang Y; Xu J; Tan Q; Jiang Y; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):1892-1901. PubMed ID: 37997376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CASC15 regulates breast cancer cell stemness via the miR-654-5p/MEF2D axis.
    Shen P; Yu Y; Yan Y; Yu B; You W
    J Biochem Mol Toxicol; 2022 May; 36(5):e23023. PubMed ID: 35235236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer.
    Bai Y; Zhang G; Cheng R; Yang R; Chu H
    Cell Cycle; 2019 Sep; 18(18):2323-2331. PubMed ID: 31378128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CASC15 promotes nasopharyngeal carcinoma cell proliferation and metastasis by downregulating miR-101-3p.
    Xue MY; Cao HX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8897-8904. PubMed ID: 31696476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
    Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
    J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation.
    Li YJ; Yang Z; Wang YY; Wang Y
    Mol Oncol; 2019 Nov; 13(11):2375-2392. PubMed ID: 31420931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00665 affects the malignant biological behavior of ovarian cancer via the miR-148b-3p/KLF5.
    Wang S; Liu C; Li Y; Qiao J; Chen X; Bao J; Li R; Xing Y
    Syst Biol Reprod Med; 2022; 68(5-6):370-383. PubMed ID: 36016468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9814-9820. PubMed ID: 31799648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
    Kong Q; Qiu M
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
    Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
    Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
    Shi P; Zhang J; Li X; Li W; Li H; Fu P
    Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
    Xin J; Zhao YH; Zhang XY; Tian LQ
    Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
    Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
    Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.